Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Anti-inflammatory Drugs
  • 1.3.3 Anti-infective Drugs
  • 1.3.4 Anti-glaucoma Drugs
  • 1.3.5 Anti-allergy Drugs
  • 1.3.6 Anti-VEGF Agents
  • 1.3.7 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Ophthalmic Therapeutic Drugs Market Share by Application (2019-2025)
  • 1.4.2 Hospital Pharmacies
  • 1.4.3 Online Pharmacies
  • 1.4.4 Independent Pharmacies & Drug Stores
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Ophthalmic Therapeutic Drugs Market Size
  • 2.1.1 Global Ophthalmic Therapeutic Drugs Revenue 2014-2025
  • 2.1.2 Global Ophthalmic Therapeutic Drugs Sales 2014-2025
• 2.2 Ophthalmic Therapeutic Drugs Growth Rate by Regions
  • 2.2.1 Global Ophthalmic Therapeutic Drugs Sales by Regions 2014-2019
  • 2.2.2 Global Ophthalmic Therapeutic Drugs Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Ophthalmic Therapeutic Drugs Sales by Manufacturers
  • 3.1.1 Ophthalmic Therapeutic Drugs Sales by Manufacturers 2014-2019
  • 3.1.2 Ophthalmic Therapeutic Drugs Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Ophthalmic Therapeutic Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Ophthalmic Therapeutic Drugs Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
• 3.3 Ophthalmic Therapeutic Drugs Price by Manufacturers
• 3.4 Key Manufacturers Ophthalmic Therapeutic Drugs Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Ophthalmic Therapeutic Drugs Market
• 3.6 Key Manufacturers Ophthalmic Therapeutic Drugs Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Anti-inflammatory Drugs Sales and Revenue (2014-2019)
  • 4.1.2 Anti-infective Drugs Sales and Revenue (2014-2019)
  • 4.1.3 Anti-glaucoma Drugs Sales and Revenue (2014-2019)
  • 4.1.4 Anti-allergy Drugs Sales and Revenue (2014-2019)
  • 4.1.5 Anti-VEGF Agents Sales and Revenue (2014-2019)
  • 4.1.6 Others Sales and Revenue (2014-2019)
• 4.2 Global Ophthalmic Therapeutic Drugs Sales Market Share by Type
• 4.3 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type
• 4.4 Ophthalmic Therapeutic Drugs Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Ophthalmic Therapeutic Drugs Sales by Application

6 United States

• 6.1 United States Ophthalmic Therapeutic Drugs Breakdown Data by Company
• 6.2 United States Ophthalmic Therapeutic Drugs Breakdown Data by Type
• 6.3 United States Ophthalmic Therapeutic Drugs Breakdown Data by Application

7 European Union

• 7.1 European Union Ophthalmic Therapeutic Drugs Breakdown Data by Company
• 7.2 European Union Ophthalmic Therapeutic Drugs Breakdown Data by Type
• 7.3 European Union Ophthalmic Therapeutic Drugs Breakdown Data by Application

8 China

• 8.1 China Ophthalmic Therapeutic Drugs Breakdown Data by Company
• 8.2 China Ophthalmic Therapeutic Drugs Breakdown Data by Type
• 8.3 China Ophthalmic Therapeutic Drugs Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Ophthalmic Therapeutic Drugs Breakdown Data by Company
• 9.2 Rest of World Ophthalmic Therapeutic Drugs Breakdown Data by Type
• 9.3 Rest of World Ophthalmic Therapeutic Drugs Breakdown Data by Application
• 9.4 Rest of World Ophthalmic Therapeutic Drugs Breakdown Data by Countries
  • 9.4.1 Rest of World Ophthalmic Therapeutic Drugs Sales by Countries
  • 9.4.2 Rest of World Ophthalmic Therapeutic Drugs Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Bayer
  • 10.1.1 Bayer Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
  • 10.1.4 Ophthalmic Therapeutic Drugs Product Introduction
  • 10.1.5 Bayer Recent Development
• 10.2 Pfizer
  • 10.2.1 Pfizer Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
  • 10.2.4 Ophthalmic Therapeutic Drugs Product Introduction
  • 10.2.5 Pfizer Recent Development
• 10.3 Novartis
  • 10.3.1 Novartis Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
  • 10.3.4 Ophthalmic Therapeutic Drugs Product Introduction
  • 10.3.5 Novartis Recent Development
• 10.4 ALLERGAN
  • 10.4.1 ALLERGAN Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
  • 10.4.4 Ophthalmic Therapeutic Drugs Product Introduction
  • 10.4.5 ALLERGAN Recent Development
• 10.5 Aerie Pharmaceuticals
  • 10.5.1 Aerie Pharmaceuticals Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
  • 10.5.4 Ophthalmic Therapeutic Drugs Product Introduction
  • 10.5.5 Aerie Pharmaceuticals Recent Development
• 10.6 Valeant Pharmaceuticals International
  • 10.6.1 Valeant Pharmaceuticals International Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
  • 10.6.4 Ophthalmic Therapeutic Drugs Product Introduction
  • 10.6.5 Valeant Pharmaceuticals International Recent Development
• 10.7 Genentech
  • 10.7.1 Genentech Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
  • 10.7.4 Ophthalmic Therapeutic Drugs Product Introduction
  • 10.7.5 Genentech Recent Development
• 10.8 Regeneron Pharmaceuticals
  • 10.8.1 Regeneron Pharmaceuticals Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
  • 10.8.4 Ophthalmic Therapeutic Drugs Product Introduction
  • 10.8.5 Regeneron Pharmaceuticals Recent Development
• 10.9 Shire
  • 10.9.1 Shire Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
  • 10.9.4 Ophthalmic Therapeutic Drugs Product Introduction
  • 10.9.5 Shire Recent Development
• 10.10 Santen Pharmaceutical
  • 10.10.1 Santen Pharmaceutical Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
  • 10.10.4 Ophthalmic Therapeutic Drugs Product Introduction
  • 10.10.5 Santen Pharmaceutical Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Ophthalmic Therapeutic Drugs Sales Channels
  • 11.2.2 Ophthalmic Therapeutic Drugs Distributors
• 11.3 Ophthalmic Therapeutic Drugs Customers

12 Market Forecast

• 12.1 Global Ophthalmic Therapeutic Drugs Sales and Revenue Forecast 2019-2025
• 12.2 Global Ophthalmic Therapeutic Drugs Sales Forecast by Type
• 12.3 Global Ophthalmic Therapeutic Drugs Sales Forecast by Application
• 12.4 Ophthalmic Therapeutic Drugs Forecast by Regions
  • 12.4.1 Global Ophthalmic Therapeutic Drugs Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Ophthalmic Therapeutic Drugs Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Ophthalmic Therapeutic Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ophthalmic Therapeutic Drugs.

This report studies the global market size of Ophthalmic Therapeutic Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Ophthalmic Therapeutic Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Bayer
Pfizer
Novartis
ALLERGAN
Aerie Pharmaceuticals
Valeant Pharmaceuticals International
Genentech
Regeneron Pharmaceuticals
Shire
Santen Pharmaceutical

Market Segment by Product Type
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others

Market Segment by Application
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Ophthalmic Therapeutic Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Ophthalmic Therapeutic Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Ophthalmic Therapeutic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025